Omega-3

Why we need to target the causes of aging

Numerous developments are driving this mainstay supplement category.

More evidence that omega-3 fatty acids are critical nutrients for the developing fetus and the growing child.

Rimfrost has awarded a contract to Westcon to build a new krill fishing vessel worth than NOK 1 billion. 

Heart health ingredients bring new science and innovation to market, despite some bad press.

A recent study published in the European Journal of Nutrition demonstrates that the patented self-micro-emulsifying delivery system (SMEDS) called AquaCelle improves that absorption of omega-3 fatty acids EPA and DHA.

The Supreme Court’s denial means that the decision of the ITC to not investigate Amarin’s complaints remains upheld by the U.S. Circuit Court of Appeals for the Circuit Court, and no further appeals are possible. 

The Global Organization for EPA and DHA Omega-3s (GOED) has published the 2017-2018 edition of its annual Global EPA and DHA Omega-3 Ingredient Market Report. 

In Nutritional Outlook's 2019 Best of the Industry Awards, we are recognizing individuals, groups, and companies whose initiatives today may help shape, for the better, the state of the dietary supplement and food and beverage industries for years to come.

OmegaQuant is giving consumers a way to measure omega-3 content-and a reason to take supplements.

NOW Methods Development team published a test method that accurately identifies the presence and levels of inorganic arsenic in krill oil.

Market researcher IRI provided its insight on which retail channels for dietary supplements are growing, or shrinking, at CRN’s The Conference.

With more U.S. adults taking dietary supplements than ever before, continued consumer confidence in the safety, quality, and efficacy of supplements will remain of utmost importance to those with stakes in the industry.

The leading nutritionist from the renowned Futbol Club Barcelona, Maria Antonia Lizarraga Dallo, MD, will be the closing keynote speaker at the GOED Exchange 2020 taking place February 4-6, 2020 in Barcelona, Spain.

Aker BioMarine has received an ‘A’ rating from the Sustainable Fisheries Partnership for the fifth year in a row. 

Natures Crops International has entered into a global supply agreement with Braini LLC for its branded Ahiflower oil (NeurXcel) which will be incorporated into the Braini memory and cognitive health platform slated for launch in December of 2019. 

Following its own evaluation of the safety and toxicology of AlaskOmega 50% and 70% omega-7 concentrates, the U.S. Food and Drug Administration does not dispute the GRAS status of the ingredient. 

Epax will be investing $35 million over the next two years to increase its capacity and innovate in the omega-3 sector. 

Results of the recently published Omega-3 to Reduce the Incidence of Preterm Birth (ORIP) trial showed that supplementation with omega-3 long chain polyunsaturated fatty acids did not lower risk of early preterm delivery. This is leading the researchers to believe a more targeted approach may be necessary. 

Bioriginal is launching a new algae-based omega-3 DHA ingredient in Europe called AlgalPure DHA. 

Even in the face of an equivocal study or two-or concerns over sourcing, regulatory setbacks, and the occasional pharma-driven lawsuit-omega-3s retain a sterling reputation that other supplements can only envy.

The equation the researchers devised might make it possible to determine how much omega-3 EPA and DHA is needed to elevate the omega-3 index to the desired level. 

Amarin Pharma has filed a petition for certiorari asking the Supreme Court to review a decision made by the U.S. Court of Appeals for the Federal Circuit to uphold a 2017 decision of the International Trade Commission (ITC) not to investigate Amarin’s complaints against manufacturers of omega-3 EPA concentrates. 

The United States Patent and Trademark Office granted the Aker BioMarine's patent application 15/040,330, which covers Aker’s Flexitech technology, used to make Superba 2 and Superba Boost krill oil products at its Houston facility.

Amarin Pharma’s recent comments advising FDA not to allow synthetic omega-3 supplements to be dietary supplements is just one more case in which synthetic supplement ingredients are under fire.